公式財務諸表に基づく売上高、利益、キャッシュフローの推移。
Fortive Corporation designs, develops, manufactures, and markets products, software, and services in the United States, China, and internationally. It operates through Intelligent Operating Solutions and Advanced Healthcare Solutions segments.
インタラクティブチャートと全財務諸表を見る → バリュエーションモデル（DCF）→
| 損益計算書 | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 売上高合計 | $4.3B | $5.1B | $6.2B | $6.1B | $5.8B | $5.3B | $4.6B | $4.6B | $6.5B | $5.8B | $6.2B | $6.2B | $6.3B | $6.0B | $5.8B |
| 売上総利益 | $2.7B | $3.1B | $3.7B | $3.6B | $3.4B | $3.0B | $2.6B | $2.5B | $3.3B | $2.9B | $3.0B | $3.0B | $3.1B | $2.9B | $2.8B |
| 売上総利益率 % | 63.2% | 61.0% | 59.9% | 59.3% | 57.7% | 57.3% | 56.5% | 54.7% | 51.5% | 50.8% | 48.9% | 48.6% | 48.2% | 48.2% | 48.1% |
| 営業利益（EBIT） | $788M | $909M | $1.2B | $1.1B | $1.0B | $832M | $650M | $529M | $1.2B | $1.2B | $1.3B | $1.3B | $1.3B | $1.2B | $1.2B |
| 営業利益率 % | 18.3% | 17.7% | 18.9% | 18.7% | 17.3% | 15.8% | 14.0% | 11.6% | 18.4% | 20.2% | 20.4% | 20.9% | 20.1% | 19.7% | 20.2% |
| 当期純利益 | $534M | $579M | $833M | $866M | $755M | $608M | $1.6B | $739M | $2.9B | $1.0B | $872M | $864M | $883M | $831M | $764M |
| 純利益率 % | 12.4% | 11.3% | 13.4% | 14.3% | 13.0% | 11.6% | 34.8% | 16.2% | 45.2% | 18.1% | 14.0% | 14.0% | 13.9% | 13.9% | 13.2% |
| EBITDA | — | $1.2B | $1.7B | $1.1B | $1.4B | $1.2B | $2.0B | $821M | $1.4B | $1.3B | $1.4B | $1.4B | $1.5B | $1.3B | $1.3B |
| 1株当たり利益（EPS） | $1.69 | $1.81 | $2.36 | $2.43 | $2.09 | $1.73 | $4.49 | $2.17 | $8.31 | $2.96 | $2.51 | $2.50 | $2.56 | $2.41 | $2.21 |
| 発行済株式数（百万株） | — | 319M | 353M | 356M | 361M | 352M | 359M | 340M | 351M | 353M | 347M | 345M | 345M | 345M | 345M |
出典: 企業の公開資料（SEC）。数値をご利用の前に SEC EDGAR でご確認ください。
貸借対照表、キャッシュフロー計算書、四半期データおよび全財務比率は FTV のインタラクティブ・ビューアーでご覧いただけます。 /companies/us/FTV
本サイトの情報は教育および情報提供のみを目的としており、投資助言ではありません。目標株価や投資判断は掲載していません。
About TickerBase · Data methodology & sources · Privacy · Terms